ACT-1004-1239
| CAS No. | 2178049-58-4 | Cat. No. | BCP46165 |
| Name | ACT-1004-1239 | ||
| Synonyms | ACT1004-1239; ACT 1004-1239; ACT-10041239; ACT-1004 1239; ACT10041239; ACT 1004 1239; | ||
| Formula | C27H28F2N6O3 | M. Wt | 522.55 |
| Description | ACT-1004-1239 is a potent, insurmountable antagonist. Oral administration of ACT-1004-1239 in mice up to 100 mg/kg led to a dose-dependent increase of plasma CXCL12 concentration. | ||
| Pathways | GPCR/G Protein | ||
| Targets | CXCR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.